AI Analysis AI Analysis of ASND
Powered by GPT-4o
New!
Stock Analysis PRO
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Ascendis Pharma A/S stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Updated on Jun 20, 2025)

Buy or Hold candidate since May 29, 2025 Gain 8.15%

The Ascendis Pharma A/S stock price gained 3.63% on the last trading day (Friday, 20th Jun 2025), rising from $170.71 to $176.90. During the last trading day the stock fluctuated 4.13% from a day low at $170.40 to a day high of $177.43. The price has fallen in 7 of the last 10 days and is down by -0.37% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 120 thousand more shares were traded than the day before. In total, 406 thousand shares were bought and sold for approximately $71.82 million.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $178.73 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.41% during the next 3 months and, with a 90% probability hold a price between $175.16 and $202.70 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

ASND Signals & Forecast

The Ascendis Pharma A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $173.09 and $165.99. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 16, 2025, and so far it has fallen -0.456%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Ascendis Pharma A/S stock

Ascendis Pharma A/S finds support from accumulated volume at $172.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $7.03 between high and low, or 4.13%. For the last week, the stock has had daily average volatility of 3.57%.

Our recommended stop-loss: $170.08 (-3.85%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (ASND) For The Upcoming Trading Day Of Monday 23rd

For the upcoming trading day on Monday, 23rd we expect Ascendis Pharma A/S to open at $174.91, and during the day (based on 14 day Average True Range), to move between $170.44 and $183.36, which gives a possible trading interval of +/-$6.46 (+/-3.65%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 7.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $177.55 (0.37%) than the support at $172.06 (2.74%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ascendis Pharma A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ascendis Pharma A/S stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.054 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2025 - $174.91 ( 1.12%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*

ASND Performance

Trading levels for ASND

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 181.95 2.85%
R2 179.26 1.33%
R1 177.60 0.395%
Price 176.90
S1 172.22 -2.64%
S2 170.56 -3.58%
S3 167.88 -5.10%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 177.71 0.458%
R1 177.55 0.367%
Price 176.90
S1 172.06 -2.74%
S2 159.13 -10.05%
S3 137.84 -22.08%

FAQ

What is the symbol for Ascendis Pharma A/S Stock and on which exchange is it traded?
The symbol for Ascendis Pharma A/S is ASND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ascendis Pharma A/S Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Ascendis Pharma A/S stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Ascendis Pharma A/S Stock?
Ascendis Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.

What's the current price of Ascendis Pharma A/S Stock?
As of the end of day on the Jun 20, 2025, the price of an Ascendis Pharma A/S (ASND) share was $176.90.

What is the 52-week high and low for Ascendis Pharma A/S Stock?
The 52-week high for Ascendis Pharma A/S Stock is $183.00 and the 52-week low is $111.09.

What is the market capitalization of Ascendis Pharma A/S Stock?
As of the Jun 20, 2025, the market capitalization of Ascendis Pharma A/S is 10.306B.

When is the next earnings date for Ascendis Pharma A/S?
The upcoming earnings date for Ascendis Pharma A/S is Sep 02, 2025.
Click to get the best stock tips daily for free!
ABOUT ASCENDIS PHARMA A/S
Ascendis Pharma A/S
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra...
GOLDEN STAR
Ticker Change Signal Date
G
GTM
$9.57
2.40% Jun 02
TAC
$8.90
23.37% May 12
IMMR
$7.28
4.81% May 09
UAA
$5.84
20.38% May 09
MEDP
$300.81
2.84% May 08

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE